![Andrew Fromkin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Fromkin
Director/Board Member at
IMMUNOVANT, INC.
Net worth: 2 M $ as of 31/07/2026
Profile
Andrew J.
Fromkin is currently Director at Immunovant Sciences Ltd. since 2019, Director at Immunovant, Inc. since 2019, and Partner at Roivant Sciences, Inc. since 2021.
Formerly, Mr. Fromkin was Chief Executive Officer at Clinical Data, Inc. in 2011; President, Chief Executive Officer & Director at Radius Health, Inc. in 2013; President & Chief Executive Officer at DoctorQuality, Inc. from 2000 to 2004; Chairman & Chief Executive Officer at Tarveda Therapeutics, Inc. from 2020 to 2021; Chief Executive Officer at Proteovant Sciences, Inc. from 2021 to 2023; President, Chief Executive Officer & Director at Endo Surgical Devices, Inc. from 2001 to 2002; Director at Regado Biosciences, Inc. from 2014 to 2016; Director at Avalon Pharmaceuticals, Inc. in 2009; Independent Director at Tobira Therapeutics, Inc. from 2015 to 2016; Director at Immunovant, Inc.; Director-Marketing & Payer Alliance at Health Information Technology from 1988 to 1993; and Vice President-Business Development at Merck-Medco Managed Care LLC from 1993 to 2000.
Mr. Fromkin completed undergraduate education at Brandeis University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMMUNOVANT INC 0.03% | 30/06/2026 | 60,502 ( 0.03% ) | 2 M $ | 31/07/2026 |
Andrew Fromkin active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNOVANT, INC. | Director/Board Member | 18/12/2019 |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Corporate Officer/Principal | 01/01/2021 |
Immunovant Sciences Ltd.
 Immunovant Sciences Ltd. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Director/Board Member | 01/10/2019 |
Former positions of Andrew Fromkin
| Companies | Position | End |
|---|---|---|
Proteovant Sciences, Inc.
 Proteovant Sciences, Inc. BiotechnologyHealth Technology Develops bi-functional molecular technology platform | Chief Executive Officer | 01/04/2023 |
Tarveda Therapeutics, Inc.
 Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops cancer therapeutics and drugs | Chief Executive Officer | 01/01/2021 |
| TOBIRA THERAPEUTICS INC | Director/Board Member | 31/10/2016 |
Regado Biosciences, Inc.
 Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antithrombotic drugs | Director/Board Member | 01/01/2016 |
| RADIUS HEALTH, INC. | Chief Executive Officer | 26/11/2013 |
Training of Andrew Fromkin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
70
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
Clinical Data, Inc.
 Clinical Data, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes scientific instruments | Health Technology |
Regado Biosciences, Inc.
Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antithrombotic drugs | Health Technology |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Merck-Medco Managed Care LLC
 Merck-Medco Managed Care LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Brandeis University
 Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avalon Pharmaceuticals, Inc.
 Avalon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics products | Health Technology |
DoctorQuality, Inc.
 DoctorQuality, Inc. Medical DistributorsDistribution Services Provides medical equipment | Distribution Services |
Endo Surgical Devices, Inc. | |
Tarveda Therapeutics, Inc.
Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops cancer therapeutics and drugs | Health Technology |
Tobira Therapeutics, Inc.
 Tobira Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and commercializes therapeutics to treat liver , inflammation, fibrosis & HIV diseases | Health Technology |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Immunovant, Inc. /Old/
 Immunovant, Inc. /Old/ BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Immunovant, Inc.
 Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Health Information Technology
 Health Information Technology MunicipalityGovernment Municipal level government authority | Government |
Proteovant Sciences, Inc.
Proteovant Sciences, Inc. BiotechnologyHealth Technology Develops bi-functional molecular technology platform | Health Technology |
- Stock Market
- Insiders
- Andrew Fromkin
